<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8997">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00786565</url>
  </required_header>
  <id_info>
    <org_study_id>001/04</org_study_id>
    <nct_id>NCT00786565</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of a New Aspheric Intraocular Lens.</brief_title>
  <official_title>Clinical Evaluation of a New Aspheric Intraocular Lens. A Prospective, Multi-Center, Comparative Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bausch &amp; Lomb Incorporated</source>
  <oversight_info>
    <authority>France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the visual performance and occurrence of posterior capsular
      opacification after implantation of a new aspherical intraocular lens compared with a
      control spherical lens of otherwise identical design.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2004</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)</study_design>
  <primary_outcome>
    <measure>Low Contrast Best Corrected Visual Acuity Following Cataract Surgery</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Low contrast best corrected visual acuity (ability to distinguish objects on a similarly colored or shaded background) 3 months following cataract surgery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Low Contrast Uncorrected Visual Acuity Following Cataract Surgery</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Low contrast uncorrected visual acuity 3 months post cataract surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Photopic Contrast Sensitivity</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The mean photopic (day light) contrast sensitivity for each spatial frequency (cycle per degree-CPD) (1.5, 3.0, 6.0, 12.0 and 18 cpd)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mesoptic Contrast Sensitivity</measure>
    <time_frame>3 Months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The mean mesoptic (low light) contrast sensitivity for each spatial frequency (cycle per degree-CPD) (1.5, 3.0, 6.0, 12.0 and 18 cpd)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Posterior Capsule Opacification Score</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Posterior Capsule Opacification Score (PCO), Density of opacification measured from 0-4 (1=minimal and 4=severe) and area of opacification measured from 0-1 (0=no opacification and 1=posterior capsule opacification required a treatment). Results (EPCO) were computer calculated by multiplying density by area of opacification.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>High Contrast Visual Acuity</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>High contrast visual acuity (ability to distinguish objects of contrasting color such as black on white) uncorrected and best corrected visual acuity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High Contrast Visual Acuity Uncorrected</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High Contrast Visual Acuity Best Corrected</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High Contrast Visual Acuity</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High Contrast Visual Acuity Uncorrected</measure>
    <time_frame>24 Months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High Contrast Visual Acuity Best Corrected</measure>
    <time_frame>24 Months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Low Contrast Visual Acuity</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Uncorrected Low contrast visual acuity - LogMar visual acuity value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast Sensitivity Photopic 1.5cpd</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>The mean photopic (day light) contrast sensitivity were to be compared between both IOLs for each special frequency (1.5, 3.0, 6.0, 12.0 and 18 cpd)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast Sensitivity Photopic</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>The mean photopic (day light) contrast sensitivity were to be compared between both IOLs for each special frequency (1.5, 3.0, 6.0, 12.0 and 18 cpd)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast Sensitivity Mesoptic 1.5 Cpd</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>The mean mesopic (dim light) contrast sensitivity were to be compared between both IOLs for each special frequency (1.5, 3.0, 6.0, 12.0 and 18 cpd)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast Sensitivity Mesoptic</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>The mean mesopic (dim light) contrast sensitivity were to be compared between both IOLs for each special frequency (1.5, 3.0, 6.0, 12.0 and 18 cpd)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Posterior Capsule Opacification</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Posterior Capsule Opacification Score (PCO), Density of opacification measured from 0-4 (1=minimal and 4=severe) and area of opacification measured from 0-1 (0=no opacification and 1=posterior capsule opacification required a treatment). Results (EPCO) were computer calculated by multiplying density by area of opacification.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Advanced Akreos Adapt</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Advanced Akreos Adapt Aspheric Intraocular Lens (IOL).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Akreos Adapt</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Akreos Adapt Spherical Intraocular Lens (IOL).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Advanced Akreos Adapt in one operated eye.</intervention_name>
    <description>Cataract surgery to implant the assigned IOL according to randomized schedule.</description>
    <arm_group_label>Advanced Akreos Adapt</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Akreos Adapt in fellow operated eye.</intervention_name>
    <description>Cataract surgery to implant the assigned IOL according to randomized schedule.</description>
    <arm_group_label>Akreos Adapt</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients must have a clinically documented diagnosis of bilateral cataract (either
             cortical, nuclear, subcapsular or a combination) liable to benefit from standard
             cataract surgery.

          -  Patients must be undergoing primary cataract surgery with IOL in-the-bag
             implantation, requiring a IOL power from 10 to 30 diopters.

        Exclusion Criteria:

          -  Patients with corneal damage.

          -  Patients with any anterior segment pathology for which extracapsular
             phacoemulsification cataract surgery would be contraindicated.

          -  Patients with any ocular pathology, other than the cataract, having repercussions on
             visual function:
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>December 2011</verification_date>
  <lastchanged_date>December 7, 2011</lastchanged_date>
  <firstreceived_date>November 3, 2008</firstreceived_date>
  <firstreceived_results_date>February 20, 2009</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment began on 12/15/2004 and ended on 04/28/2006. This study was conducted at 5 European sites.</recruitment_details>
      <pre_assignment_details>Planned enrollment was to consist of 120 subjects, due to difficulties in enrolling subjects within the designated 6 month enrollment window 75 subjects were entered into the study for a total of 150 treated eyes.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Akreos Intraocular Lens</title>
          <description>Subjects randomised to receive Akreos Advanced Optic Aspheric Intraocular Lens in one eye and Akreos Adapt Spherical Intraocular Lens in the fellow eye.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Enrollment Prior to Surgery</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="75"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="69">69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Site Closed</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Post Surgery</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="69"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="67">67 Participants (134 eyes) completed the study.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Abnormal macular pucker</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adapt AO implanted posterior side up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Akreos Intraocular Lens</title>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="69"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <description>69 participants (138 eyes)were randomised to receive Akreos Advanced Optic Aspheric Intraocular Lens in one eye (69 eyes) and Akreos Adapt Spherical Intraocular Lens in the fellow eye (69 eyes).</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <sub_title>Between 50 and 85 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="73.0" spread="7.21"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="37"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="32"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Europe</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="69"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Low Contrast Best Corrected Visual Acuity Following Cataract Surgery</title>
        <description>Low contrast best corrected visual acuity (ability to distinguish objects on a similarly colored or shaded background) 3 months following cataract surgery.</description>
        <time_frame>3 months</time_frame>
        <safety_issue>No</safety_issue>
        <population>Number of participants 67 total with 67 eyes in each group, full analysis set, all randomized participants who had cataract surgery one intraocular lens (IOL) in each eye, and who had at least one baseline value and one post-baseline value for efficacy.</population>
        <group_list>
          <group group_id="O1">
            <title>Akreos Advanced Optics</title>
            <description>Akreos Advanced Optics Intraocular Lens</description>
          </group>
          <group group_id="O2">
            <title>Akreos Adapt</title>
            <description>Akreos Adapt Intraocular Lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="67"/>
                  <measurement group_id="O2" value="67"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Low Contrast Best Corrected Visual Acuity Following Cataract Surgery</title>
            <description>Low contrast best corrected visual acuity (ability to distinguish objects on a similarly colored or shaded background) 3 months following cataract surgery.</description>
            <units>LogMAR</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="0.22" spread="0.096"/>
                  <measurement group_id="O2" value="0.24" spread="0.131"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Low Contrast Uncorrected Visual Acuity Following Cataract Surgery</title>
        <description>Low contrast uncorrected visual acuity 3 months post cataract surgery</description>
        <time_frame>3 months</time_frame>
        <safety_issue>No</safety_issue>
        <population>Full analysis set, all randomized participants who had cataract surgery one intraocular lens (IOL) in each eye, and who had at least one baseline value and one post-baseline value for efficacy</population>
        <group_list>
          <group group_id="O1">
            <title>Akreos Advanced Optics</title>
            <description>Akreos Advanced Optics Intraocular Lens</description>
          </group>
          <group group_id="O2">
            <title>Akreos Adapt</title>
            <description>Akreos Adapt Intraocular Lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="68"/>
                  <measurement group_id="O2" value="68"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Low Contrast Uncorrected Visual Acuity Following Cataract Surgery</title>
            <description>Low contrast uncorrected visual acuity 3 months post cataract surgery</description>
            <units>LogMAR</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="0.33" spread="0.163"/>
                  <measurement group_id="O2" value="0.35" spread="0.191"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Photopic Contrast Sensitivity</title>
        <description>The mean photopic (day light) contrast sensitivity for each spatial frequency (cycle per degree-CPD) (1.5, 3.0, 6.0, 12.0 and 18 cpd)</description>
        <time_frame>3 months</time_frame>
        <safety_issue>No</safety_issue>
        <population>All patients who had cataract surgery and who have at least one baseline value and one post-baseline value for efficacy criteria.</population>
        <group_list>
          <group group_id="O1">
            <title>Akreos Advanced Optics</title>
            <description>Akreos Advanced Optics Intraocular Lens</description>
          </group>
          <group group_id="O2">
            <title>Akreos Adapt</title>
            <description>Akreos Adapt Intraocular Lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="68"/>
                  <measurement group_id="O2" value="68"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Photopic Contrast Sensitivity</title>
            <description>The mean photopic (day light) contrast sensitivity for each spatial frequency (cycle per degree-CPD) (1.5, 3.0, 6.0, 12.0 and 18 cpd)</description>
            <units>Log 10</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>Photopic Contrast Sensitivity - 1.5</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="44.4" spread="22.5"/>
                  <measurement group_id="O2" value="41.1" spread="21.3"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Photopic Contrast Sensitivity - 3.0</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="78.3" spread="36.2"/>
                  <measurement group_id="O2" value="81.1" spread="38.5"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Photopic Contrast Sensitivity - 6.0</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="89.6" spread="48.4"/>
                  <measurement group_id="O2" value="86.4" spread="45.5"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Photopic Contrast Sensitivity - 12.0</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="29.3" spread="18.3"/>
                  <measurement group_id="O2" value="26.7" spread="20.4"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Photopic Contrast Sensitivity - 18.0</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="11.4" spread="9.6"/>
                  <measurement group_id="O2" value="10.1" spread="10.7"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>High Contrast Visual Acuity</title>
        <description>High contrast visual acuity (ability to distinguish objects of contrasting color such as black on white) uncorrected and best corrected visual acuity.</description>
        <time_frame>1 month</time_frame>
        <safety_issue>No</safety_issue>
        <population>Patients without missing values for HCVA logmar at pre-operative and post operative at 1 month control.</population>
        <group_list>
          <group group_id="O1">
            <title>Akreos Advanced Optics</title>
            <description>Akreos Advanced Optics Intraocular Lens</description>
          </group>
          <group group_id="O2">
            <title>Akreos Adapt</title>
            <description>Akreos Adapt Intraocular Lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="66"/>
                  <measurement group_id="O2" value="66"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>High Contrast Visual Acuity</title>
            <description>High contrast visual acuity (ability to distinguish objects of contrasting color such as black on white) uncorrected and best corrected visual acuity.</description>
            <units>LogMAR</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>Uncorrected</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.13" spread="0.20"/>
                  <measurement group_id="O2" value="0.18" spread="0.21"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Best Corrected</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.02" spread="0.13"/>
                  <measurement group_id="O2" value="0.05" spread="0.14"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>High Contrast Visual Acuity Uncorrected</title>
        <time_frame>3 months</time_frame>
        <safety_issue>No</safety_issue>
        <population>Patients without missing values for UHCVA logmar at pre-operative and post operative at 1 month control.</population>
        <group_list>
          <group group_id="O1">
            <title>Akreos Advanced Optics</title>
            <description>Akreos Advanced Optics Intraocular Lens</description>
          </group>
          <group group_id="O2">
            <title>Akreos Adapt</title>
            <description>Akreos Adapt Intraocular Lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="66"/>
                  <measurement group_id="O2" value="67"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>High Contrast Visual Acuity Uncorrected</title>
            <units>LogMAR</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="0.15" spread="0.19"/>
                  <measurement group_id="O2" value="0.18" spread="0.22"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>High Contrast Visual Acuity Best Corrected</title>
        <time_frame>3 months</time_frame>
        <safety_issue>No</safety_issue>
        <population>Patients without missing values for BHCVA logmar at pre-operative and post operative at 1 month control.</population>
        <group_list>
          <group group_id="O1">
            <title>Akreos Advanced Optics</title>
            <description>Akreos Advanced Optics Intraocular Lens</description>
          </group>
          <group group_id="O2">
            <title>Akreos Adapt</title>
            <description>Akreos Adapt Intraocular Lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="64"/>
                  <measurement group_id="O2" value="66"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>High Contrast Visual Acuity Best Corrected</title>
            <units>LogMAR</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="0.03" spread="0.12"/>
                  <measurement group_id="O2" value="0.04" spread="0.13"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>High Contrast Visual Acuity</title>
        <time_frame>12 months</time_frame>
        <safety_issue>No</safety_issue>
        <population>Patients without missing values for HCVA logmar at pre-operative and post operative at 1 month control.</population>
        <group_list>
          <group group_id="O1">
            <title>Akreos Advanced Optics</title>
            <description>Akreos Advanced Optics Intraocular Lens</description>
          </group>
          <group group_id="O2">
            <title>Akreos Adapt</title>
            <description>Akreos Adapt Intraocular Lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="60"/>
                  <measurement group_id="O2" value="60"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>High Contrast Visual Acuity</title>
            <units>LogMAR</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>Uncorrected</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.17" spread="0.19"/>
                  <measurement group_id="O2" value="0.22" spread="0.22"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Best Corrected</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.05" spread="0.13"/>
                  <measurement group_id="O2" value="0.07" spread="0.13"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mesoptic Contrast Sensitivity</title>
        <description>The mean mesoptic (low light) contrast sensitivity for each spatial frequency (cycle per degree-CPD) (1.5, 3.0, 6.0, 12.0 and 18 cpd)</description>
        <time_frame>3 Months</time_frame>
        <safety_issue>No</safety_issue>
        <population>All patients who had cataract surgery and who have at least one baseline value and one post-baseline value for efficacy criteria.</population>
        <group_list>
          <group group_id="O1">
            <title>Akreos Advanced Optics</title>
            <description>Akreos Advanced Optics Intraocular Lens</description>
          </group>
          <group group_id="O2">
            <title>Akreos Adapt</title>
            <description>Akreos Adapt Intraocular Lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="68"/>
                  <measurement group_id="O2" value="67"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Mesoptic Contrast Sensitivity</title>
            <description>The mean mesoptic (low light) contrast sensitivity for each spatial frequency (cycle per degree-CPD) (1.5, 3.0, 6.0, 12.0 and 18 cpd)</description>
            <units>Log 10</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>Mesopic Contrast Sensitivity - 1.5</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="51.2" spread="27.0"/>
                  <measurement group_id="O2" value="47.4" spread="25.4"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Mesopic Contrast Sensitivity - 3.0</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="65.6" spread="35.6"/>
                  <measurement group_id="O2" value="58.1" spread="35.0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Mesopic Contrast Sensitivity - 6.0</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="52.9" spread="33.5"/>
                  <measurement group_id="O2" value="45.6" spread="29.4"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Mesopic Contrast Sensitivity - 12.0</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="9.5" spread="10.2"/>
                  <measurement group_id="O2" value="9.5" spread="13.0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Mesopic Contrast Sensitivity - 18.0</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.7" spread="4.9"/>
                  <measurement group_id="O2" value="2.0" spread="3.3"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Posterior Capsule Opacification Score</title>
        <description>Posterior Capsule Opacification Score (PCO), Density of opacification measured from 0-4 (1=minimal and 4=severe) and area of opacification measured from 0-1 (0=no opacification and 1=posterior capsule opacification required a treatment). Results (EPCO) were computer calculated by multiplying density by area of opacification.</description>
        <time_frame>24 months</time_frame>
        <safety_issue>No</safety_issue>
        <population>The EPCO score, evaluated by an independent observer using retro-illumination pictures, all pictures available. Measured in a 3mm and 6mm optic area.</population>
        <group_list>
          <group group_id="O1">
            <title>Akreos Advanced Optics</title>
            <description>Akreos Advanced Optics Intraocular Lens</description>
          </group>
          <group group_id="O2">
            <title>Akreos Adapt</title>
            <description>Akreos Adapt Intraocular Lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="34"/>
                  <measurement group_id="O2" value="30"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Posterior Capsule Opacification Score</title>
            <description>Posterior Capsule Opacification Score (PCO), Density of opacification measured from 0-4 (1=minimal and 4=severe) and area of opacification measured from 0-1 (0=no opacification and 1=posterior capsule opacification required a treatment). Results (EPCO) were computer calculated by multiplying density by area of opacification.</description>
            <units>EPCO Score</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>PCO Score 3mm</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.05" spread="0.14"/>
                  <measurement group_id="O2" value="0.14" spread="0.24"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>PCO Score 6mm</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.12" spread="0.24"/>
                  <measurement group_id="O2" value="0.20" spread="0.31"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>High Contrast Visual Acuity Uncorrected</title>
        <time_frame>24 Months</time_frame>
        <safety_issue>No</safety_issue>
        <population>Patients without missing values for UHCVA logmar at pre-operative and post operative at 1 month control.</population>
        <group_list>
          <group group_id="O1">
            <title>Akreos Advanced Optics</title>
            <description>Akreos Advanced Optics Intraocular Lens</description>
          </group>
          <group group_id="O2">
            <title>Akreos Adapt</title>
            <description>Akreos Adapt Intraocular Lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="55"/>
                  <measurement group_id="O2" value="55"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>High Contrast Visual Acuity Uncorrected</title>
            <units>LogMar</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="0.22" spread="0.18"/>
                  <measurement group_id="O2" value="0.27" spread="0.23"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>High Contrast Visual Acuity Best Corrected</title>
        <time_frame>24 Months</time_frame>
        <safety_issue>No</safety_issue>
        <population>Patients without missing values for best corrected HCVA logmar at pre-operative and post operative at 1 month control.</population>
        <group_list>
          <group group_id="O1">
            <title>Akreos Advanced Optics</title>
            <description>Akreos Advanced Optics Intraocular Lens</description>
          </group>
          <group group_id="O2">
            <title>Akreos Adapt</title>
            <description>Akreos Adapt Intraocular Lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="52"/>
                  <measurement group_id="O2" value="52"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>High Contrast Visual Acuity Best Corrected</title>
            <units>LogMar</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="0.11" spread="0.14"/>
                  <measurement group_id="O2" value="0.15" spread="0.19"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Low Contrast Visual Acuity</title>
        <description>Uncorrected Low contrast visual acuity - LogMar visual acuity value</description>
        <time_frame>1 month</time_frame>
        <safety_issue>No</safety_issue>
        <population>All patients who had cataract surgery and who have at least one baseline value and one post-baseline value for efficacy criteria.</population>
        <group_list>
          <group group_id="O1">
            <title>Akreos Advanced Optics</title>
            <description>Akreos Advanced Optics Intraocular Lens</description>
          </group>
          <group group_id="O2">
            <title>Akreos Adapt</title>
            <description>Akreos Adapt Intraocular Lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="68"/>
                  <measurement group_id="O2" value="68"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Low Contrast Visual Acuity</title>
            <description>Uncorrected Low contrast visual acuity - LogMar visual acuity value</description>
            <units>LogMar</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>Uncorrected</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.33" spread="0.17"/>
                  <measurement group_id="O2" value="0.36" spread="0.19"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Best Corrected</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.21" spread="0.13"/>
                  <measurement group_id="O2" value="0.24" spread="0.12"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Contrast Sensitivity Photopic 1.5cpd</title>
        <description>The mean photopic (day light) contrast sensitivity were to be compared between both IOLs for each special frequency (1.5, 3.0, 6.0, 12.0 and 18 cpd)</description>
        <time_frame>1 month</time_frame>
        <safety_issue>No</safety_issue>
        <population>All patients who had cataract surgery and who have at least one baseline value and one post-baseline value for efficacy criteria.</population>
        <group_list>
          <group group_id="O1">
            <title>Akreos Advanced Optics</title>
            <description>Akreos Advanced Optics Intraocular Lens</description>
          </group>
          <group group_id="O2">
            <title>Akreos Adapt</title>
            <description>Akreos Adapt Intraocular Lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="67"/>
                  <measurement group_id="O2" value="67"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Contrast Sensitivity Photopic 1.5cpd</title>
            <description>The mean photopic (day light) contrast sensitivity were to be compared between both IOLs for each special frequency (1.5, 3.0, 6.0, 12.0 and 18 cpd)</description>
            <units>Log 10</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="39.2" spread="20.80"/>
                  <measurement group_id="O2" value="39.9" spread="20.08"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Contrast Sensitivity Photopic</title>
        <description>The mean photopic (day light) contrast sensitivity were to be compared between both IOLs for each special frequency (1.5, 3.0, 6.0, 12.0 and 18 cpd)</description>
        <time_frame>1 month</time_frame>
        <safety_issue>No</safety_issue>
        <population>All patients who had cataract surgery and who have at least one baseline value and one post-baseline value for efficacy criteria.</population>
        <group_list>
          <group group_id="O1">
            <title>Akreos Advanced Optics</title>
            <description>Akreos Advanced Optics Intraocular Lens</description>
          </group>
          <group group_id="O2">
            <title>Akreos Adapt</title>
            <description>Akreos Adapt Intraocular Lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="66"/>
                  <measurement group_id="O2" value="66"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Contrast Sensitivity Photopic</title>
            <description>The mean photopic (day light) contrast sensitivity were to be compared between both IOLs for each special frequency (1.5, 3.0, 6.0, 12.0 and 18 cpd)</description>
            <units>Log 10</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>Photopic contrast sensitivity - 3.0</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="76.6" spread="36.38"/>
                  <measurement group_id="O2" value="64.0" spread="27.83"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Photopic contrast sensitivity - 6.0</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="92.4" spread="46.34"/>
                  <measurement group_id="O2" value="70.5" spread="39.15"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Photopic contrast sensitivity - 12.0</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="30.3" spread="21.46"/>
                  <measurement group_id="O2" value="22.3" spread="17.60"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Photopic contrast sensitivity - 18.0</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="11.0" spread="9.12"/>
                  <measurement group_id="O2" value="8.3" spread="8.90"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Contrast Sensitivity Mesoptic 1.5 Cpd</title>
        <description>The mean mesopic (dim light) contrast sensitivity were to be compared between both IOLs for each special frequency (1.5, 3.0, 6.0, 12.0 and 18 cpd)</description>
        <time_frame>1 month</time_frame>
        <safety_issue>No</safety_issue>
        <population>All patients who had cataract surgery and who have at least one baseline value and one post-baseline value for efficacy criteria.</population>
        <group_list>
          <group group_id="O1">
            <title>Akreos Advanced Optics</title>
            <description>Akreos Advanced Optics Intraocular Lens</description>
          </group>
          <group group_id="O2">
            <title>Akreos Adapt</title>
            <description>Akreos Adapt Intraocular Lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="67"/>
                  <measurement group_id="O2" value="67"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Contrast Sensitivity Mesoptic 1.5 Cpd</title>
            <description>The mean mesopic (dim light) contrast sensitivity were to be compared between both IOLs for each special frequency (1.5, 3.0, 6.0, 12.0 and 18 cpd)</description>
            <units>Log 10</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="46.6" spread="25.21"/>
                  <measurement group_id="O2" value="40.8" spread="21.74"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Contrast Sensitivity Mesoptic</title>
        <description>The mean mesopic (dim light) contrast sensitivity were to be compared between both IOLs for each special frequency (1.5, 3.0, 6.0, 12.0 and 18 cpd)</description>
        <time_frame>1 month</time_frame>
        <safety_issue>No</safety_issue>
        <population>All patients who had cataract surgery and who have at least one baseline value and one post-baseline value for efficacy criteria.</population>
        <group_list>
          <group group_id="O1">
            <title>Akreos Advanced Optics</title>
            <description>Akreos Advanced Optics Intraocular Lens</description>
          </group>
          <group group_id="O2">
            <title>Akreos Adapt</title>
            <description>Akreos Adapt Intraocular Lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="66"/>
                  <measurement group_id="O2" value="66"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Contrast Sensitivity Mesoptic</title>
            <description>The mean mesopic (dim light) contrast sensitivity were to be compared between both IOLs for each special frequency (1.5, 3.0, 6.0, 12.0 and 18 cpd)</description>
            <units>Log 10</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>Mesoptic contrast sensitivity - 3.0</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="58.2" spread="28.08"/>
                  <measurement group_id="O2" value="51.5" spread="29.57"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Mesoptic contrast sensitivity - 6.0</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="55.9" spread="40.56"/>
                  <measurement group_id="O2" value="39.4" spread="28.32"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Mesoptic contrast sensitivity - 12.0</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="9.2" spread="10.29"/>
                  <measurement group_id="O2" value="6.7" spread="10.21"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Mesoptic contrast sensitivity - 18.0</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.8" spread="4.97"/>
                  <measurement group_id="O2" value="2.2" spread="3.84"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Posterior Capsule Opacification</title>
        <description>Posterior Capsule Opacification Score (PCO), Density of opacification measured from 0-4 (1=minimal and 4=severe) and area of opacification measured from 0-1 (0=no opacification and 1=posterior capsule opacification required a treatment). Results (EPCO) were computer calculated by multiplying density by area of opacification.</description>
        <time_frame>12 months</time_frame>
        <safety_issue>No</safety_issue>
        <population>The EPCO score, evaluated by an independent observer using retro-illumination pictures, all pictures available. Measured in a 3mm and 6mm optic area.</population>
        <group_list>
          <group group_id="O1">
            <title>Akreos Advanced Optics</title>
            <description>Akreos Advanced Optics Intraocular Lens</description>
          </group>
          <group group_id="O2">
            <title>Akreos Adapt</title>
            <description>Akreos Adapt Intraocular Lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="40"/>
                  <measurement group_id="O2" value="39"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Posterior Capsule Opacification</title>
            <description>Posterior Capsule Opacification Score (PCO), Density of opacification measured from 0-4 (1=minimal and 4=severe) and area of opacification measured from 0-1 (0=no opacification and 1=posterior capsule opacification required a treatment). Results (EPCO) were computer calculated by multiplying density by area of opacification.</description>
            <units>EPCO Score</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>PCO Score - 3mm</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.03" spread="0.095"/>
                  <measurement group_id="O2" value="0.06" spread="0.133"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>PCO Score - 6 mm</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.07" spread="0.148"/>
                  <measurement group_id="O2" value="0.13" spread="0.195"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Ocular adverse events were measured over 24 month study period.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Akreos Advanced Intraocular Lenses</title>
          <description>Akreos Advanced Optic Aspheric Intraocular Lens in one eye and Akreos Adapt Spherical Intraocular Lens in the fellow eye.</description>
        </group>
        <group group_id="E2">
          <title>Akreos Adapt Intraocular Lens</title>
          <description>Akreos Advanced Optic Aspheric Intraocular Lens in one eye and Akreos Adapt Spherical Intraocular Lens in the fellow eye.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jon Hayashida</name_or_title>
      <organization>Bausch &amp; Lomb</organization>
      <phone>(585) 338-6370</phone>
      <email>jon.hayashida@bausch.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
